|
Mr. Anderson currently serves as the Chief Financial Officer and Vice President Finance & Administration of Dow Pharmaceutical Inc. Mr. Anderson has more than 30 years of healthcare industry experience primarily focused in financial management within the biopharmaceutical sector. Prior to joining Dow in 2003 he was Chief Financial Officer for Transurgical Inc. a private medical technology company. Prior to that Mr. Anderson served as Chief Operating Officer and Chief Financial Officer at BioMarin Pharmaceutical Inc. from June 1998 to December 2001. Prior to June 1998 Mr. Anderson has held similar executive-level positions with other biopharmaceutical companies including Syntex Chiron Glycomed and Fusion Medical Technologies.
Mr. Anderson holds an M.B.A. from Harvard University; an M.S. in Administration from George Washington University; and a B.S. in Engineering from the United States Military Academy. | 